This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Universiteit Hasselt, University of Ghent. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 41 
1 out of 505 
Years Active: 2019
Title: Michelle Plusquin: Innovator in Carcinogenicity Detection
Introduction
Michelle Plusquin is a notable inventor based in Bilzen, Belgium. She has made significant contributions to the field of carcinogenicity detection, particularly through her innovative research involving flatworms. Her work focuses on developing methods to predict the carcinogenicity of various compounds.
Latest Patents
Michelle Plusquin holds 1 patent titled "Methods to detect non-genotoxic carcinogens using flatworms." This patent discloses methods for determining whether a compound is a non-genotoxic carcinogen. It also outlines techniques to differentiate between genotoxic and non-genotoxic carcinogens based on in vivo stem cell proliferation patterns observed in flatworms.
Career Highlights
Throughout her career, Michelle has worked with esteemed institutions such as the University of Ghent and Universiteit Hasselt. Her research has garnered attention for its potential applications in toxicology and public health.
Collaborations
Michelle has collaborated with notable colleagues, including Karen Smeets and An-Sofie Stevens, contributing to her research and development efforts in the field.
Conclusion
Michelle Plusquin's innovative work in detecting non-genotoxic carcinogens represents a significant advancement in understanding carcinogenicity. Her contributions are vital for future research and applications in health and safety.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile